The science behind excipients: Unveiling the impact of lactose in drug formulations
Introduction
In the realm of pharmaceutical formulations, excipients are indispensable, enhancing the safety, efficacy, stability, manufacturability, and patient acceptability of drug products. While active pharmaceutical ingredients (APIs) deliver therapeutic effects, excipients like lactose play a crucial role in ensuring effective manufacturing, storage, administration, and absorption. Lactose is particularly noteworthy due to its favourable physicochemical properties, broad regulatory acceptance, and excellent safety profile.
Lactose: A key player in drug formulation success
Pharmaceutical formulation development is a complex process involving the careful selection and optimization of both active pharmaceutical ingredients (APIs) and excipients. Historically considered as inert substances whose sole purpose was to provide bulk to formulations, excipients are now recognized for their critical role in influencing the quality, performance, and therapeutic success of drug products.
The increasing complexity of drug molecules, especially poorly soluble compounds and biologics, underscores the importance of selecting the right excipients during formulation development.
Excipients affect various product attributes, including:
- Tablet hardness and friability
- Drug dissolution and bioavailability
- Stability during storage
- Manufacturing efficiency
- Patient compliance
- Product appearance and acceptability
Lactose holds a unique position among pharmaceutical excipients due to its long-standing use, favourable physicochemical properties, and multifunctional characteristics.
For over a century, lactose has been a staple in pharmaceutical formulations globally, with an estimated 60–70% of solid oral dosage forms containing lactose in some form. Its widespread use is attributed to its availability, cost-effectiveness, excellent flow properties, compressibility, neutral taste, and broad regulatory acceptance.
The selection of excipients is driven by a thorough understanding of API characteristics and desired product performance. Lactose often serves multiple roles simultaneously, simplifying formulation complexity.
Harnessing the multifunctionality of lactose in formulations
One of the most significant advantages of lactose is its multifunctionality, which makes it an invaluable component in pharmaceutical formulations.
Lactose as a diluent
Diluents are used to increase the bulk of a formulation when the API dose is too small to produce a tablet or capsule of practical size.
Many modern APIs, such as hormones, oncology drugs, and steroids, are highly potent and administered at low doses.
A tablet containing only a few milligrams of API would be challenging to manufacture and handle.
Lactose provides the necessary bulk while ensuring dose uniformity.
Lactose as a binder
Binders are essential for promoting particle adhesion and maintaining tablet integrity after compression.
Lactose contributes to particle bonding during compression, offering various benefits such as:
- Improved tablet hardness
- Reduced friability
- Enhanced mechanical strength
These properties are particularly valuable in direct compression formulations.
Lactose as a carrier in dry powder inhalers
Drug particles intended for pulmonary delivery are often extremely fine and difficult to handle.
Lactose serves as a carrier particle by:
- Improving powder flow
- Enhancing dose uniformity
- Facilitating drug dispersion during inhalation
Numerous marketed inhalation products employ lactose as the carrier excipient.
Lactose as a stabilizer
Stabilizers protect APIs from physical or chemical degradation.
In lyophilized products and protein formulations, lactose may stabilize sensitive biomolecules through mechanisms such as:
- Water replacement mechanisms
- Glass formation
- Reduced molecular mobility
This protection helps maintain biological activity during storage.
Conclusion
Lactose continues to be a cornerstone in pharmaceutical excipient technology, celebrated for its versatility, safety, cost-effectiveness, and outstanding functional properties. Far beyond its role as a mere filler, lactose significantly impacts formulation attributes such as powder flow, compressibility, tablet hardness, dissolution behaviour, and product stability. The development of specialized lactose grades has been tailored to meet the demands of modern pharmaceutical manufacturing processes, including direct compression and inhalation technologies.
As advancements in particle engineering progress, lactose is expected to maintain its pivotal role in pharmaceutical formulation science. This evolution underscores the growing understanding that excipients are not just inactive ingredients but vital contributors to the quality, efficacy, and performance of drug products.
Discover more about our pharmaceutical lactose grades and how they can support your formulations:
Milled & Sieved: Ideal for wet / dry granulation for tablets manufacturing (milled lactose) and capsules or sachets filling (sieved lactose)
Direct Compression: Designed for efficient direct compression tablet manufacturing, offering excellent compaction and flow properties
Dry Powder Inhalation (DPI):Tailored for inhalation products, ensuring optimal particle size and consistency for respiratory applications
References
-
Rowe RC, Sheskey PJ, Quinn ME. Handbook of Pharmaceutical Excipients, Pharmaceutical Press.
-
Aulton ME, Taylor K. Aulton's Pharmaceutics: The Design and Manufacture of Medicines.
-
Swarbrick J. Encyclopedia of Pharmaceutical Technology.
-
United States Pharmacopeia (USP–NF), Lactose Monographs.
-
European Pharmacopoeia (Ph. Eur.), Lactose and Lactose Monohydrate Monographs.
-
Armstrong NA. Pharmaceutical Excipients and Their Functionality in Solid Dosage Forms.
-
Bolhuis GK, Chowhan ZT. Materials for Direct Compression. Pharmaceutical Powder Compaction Technology.
